Mark Joseph Enyedy currently works at ImmunoGen, Inc., as President & Chief Executive Officer, BioMarin Pharmaceutical, Inc., as Independent Director from 2023, Biotechnology Innovation Organization, ...

Detailed price information for Corbus Pharmaceuticals Hldgs Inc (CRBP-Q) from The Globe and Mail including charting and trades.

Inovio Pharmaceuticals Inc. closed 84.02% below its 52-week high of $12.33, which the company reached on July 26th.

Pelareorep initiates a pro-inflammatory tumor microenvironment (TME) and induces innate and adaptive immune responses New ...

When Columbia neurologist and scientist Neil Shneider speaks to his ALS patients who volunteer for experimental therapies, he's unwaveringly honest.

Biotechnology students were selected to participate in the competitive Wistar Institute’s Biomedical Technician Training ...

Eikon Therapeutics, a Bay Area biotech startup with $1.1 billion in funding, is laying off dozens of employees and pointing ...

Federal jurors in Delaware found that Amgen violated antitrust laws by bundling its cholesterol treatment with substantial ...

Clymb Clinical is proud to announce the launch of TFL Viewer, a state-of-the-art SaaS application designed to streamline the ...

Discover how hot melt extrusion supports polypharmacy reduction and novel therapies for stroke and snakebite with expert insights.

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...